ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,319Medicare Part D Prescriptions Filled, Including Refills

Rank: 14 out of 54

$528K Total Retail Price of All Prescriptions

Rank: 9 out of 54

184 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

26% of this provider’s 184 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 5,670 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
WARFARIN SODIUM 441 325 1 7
SIMVASTATIN 370 265 2 3
LISINOPRIL 245 181 3 2
METFORMIN HCL 232 195 4 11
AMLODIPINE BESYLATE 228 170 5 6
GABAPENTIN 206 102 6 13
LEVOTHYROXINE SODIUM 192 135 7 1
OMEPRAZOLE 168 112 8 4
CITALOPRAM HBR 161 110 9 9
FUROSEMIDE 157 123 10 5
POTASSIUM CHLORIDE 153 115 11 12
METOPROLOL TARTRATE 148 75 12 10
MIRTAZAPINE 147 112 13 18
RISPERIDONE 145 120 14 38
SERTRALINE HCL 142 76 15 21
LANTUS 133 106 16 39
QUETIAPINE FUMARATE 129 107 17 30
OXYCODONE HCL 126 92 S2 18 26
METOPROLOL SUCCINATE 120 97 19 20
TAMSULOSIN HCL 96 89 20 25
OLANZAPINE 94 71 21 113
ATENOLOL 91 76 22 17
RAMIPRIL 87 86 23 138
ALBUTEROL SULFATE 87 59 23 99
LEVETIRACETAM 87 58 23 112
FLUOXETINE HCL 83 51 26 45
ALENDRONATE SODIUM 77 59 27 23
HYDROCHLOROTHIAZIDE 71 69 28 14
METHADONE HCL 70 0 S2 29 70
BACLOFEN 69 0 30 65
CARVEDILOL 67 51 31 36
LOVASTATIN 62 49 32 31
RANITIDINE HCL 61 32 33 33
DONEPEZIL HCL 61 61 33 15
LIDODERM 60 47 35 92
ISOSORBIDE MONONITRATE ER 58 41 36 57
ATORVASTATIN CALCIUM 57 37 37 19
VENLAFAXINE HCL ER 54 26 38 87
CARBIDOPA-LEVODOPA 53 35 39 42
AMITRIPTYLINE HCL 53 0 R 39 70
LACTULOSE 53 47 39 122
DIGOXIN 52 40 42 40
SULFAMETHOXAZOLE-TRIMETHOPRIM 52 32 42 105
NAMENDA 51 51 44 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.